Strebhardt K - Search Results

1

Paul Ehrlich's magic bullet concept: 100 years of progress.

Strebhardt K, Ullrich A. Strebhardt K, et al. Nat Rev Cancer. 2008 Jun;8(6):473-80. doi: 10.1038/nrc2394. Epub 2008 May 12. Nat Rev Cancer. 2008. PMID: 18469827 Review.

2

Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.

Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. Knecht R, et al. Among authors: strebhardt k. Cancer Res. 1999 Jun 15;59(12):2794-7. Cancer Res. 1999. PMID: 10383133

3

Efficient internalization of the polo-box of polo-like kinase 1 fused to an Antennapedia peptide results in inhibition of cancer cell proliferation.

Yuan J, Krämer A, Eckerdt F, Kaufmann M, Strebhardt K. Yuan J, et al. Among authors: strebhardt k. Cancer Res. 2002 Aug 1;62(15):4186-90. Cancer Res. 2002. PMID: 12154015

4

Expression of endothelial and inducible nitric oxide synthase in benign and malignant lesions of the breast and measurement of nitric oxide using electron paramagnetic resonance spectroscopy.

Loibl S, von Minckwitz G, Weber S, Sinn HP, Schini-Kerth VB, Lobysheva I, Nepveu F, Wolf G, Strebhardt K, Kaufmann M. Loibl S, et al. Among authors: strebhardt k. Cancer. 2002 Sep 15;95(6):1191-8. doi: 10.1002/cncr.10817. Cancer. 2002. PMID: 12216084

5

Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells.

Spänkuch-Schmitt B, Bereiter-Hahn J, Kaufmann M, Strebhardt K. Spänkuch-Schmitt B, et al. Among authors: strebhardt k. J Natl Cancer Inst. 2002 Dec 18;94(24):1863-77. doi: 10.1093/jnci/94.24.1863. J Natl Cancer Inst. 2002. PMID: 12488480

6

Carcinomas unresponsive to either cisplatinum or anti-EGFR therapy can be growth inhibited by combination therapy of both agents.

Knecht R, Peters S, Adunka O, Strebhardt K, Gstoettner W, Hambek M. Knecht R, et al. Among authors: strebhardt k. Anticancer Res. 2003 May-Jun;23(3B):2577-83. Anticancer Res. 2003. PMID: 12894544

7

Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1.

Spänkuch B, Matthess Y, Knecht R, Zimmer B, Kaufmann M, Strebhardt K. Spänkuch B, et al. Among authors: strebhardt k. J Natl Cancer Inst. 2004 Jun 2;96(11):862-72. doi: 10.1093/jnci/djh146. J Natl Cancer Inst. 2004. PMID: 15173270

8

STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.

Hambek M, Baghi M, Strebhardt K, May A, Adunka O, Gstöttner W, Knecht R. Hambek M, et al. Among authors: strebhardt k. Anticancer Res. 2004 Nov-Dec;24(6):3881-6. Anticancer Res. 2004. PMID: 15736426

9

Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).

Hambek M, Baghi M, Baumaun H, Strebhardt K, Adunka O, Gstöttner W, Knecht R. Hambek M, et al. Among authors: strebhardt k. Anticancer Res. 2005 May-Jun;25(3B):1871-5. Anticancer Res. 2005. PMID: 16158919

10

Targeting polo-like kinase 1 for cancer therapy.

Strebhardt K, Ullrich A. Strebhardt K, et al. Nat Rev Cancer. 2006 Apr;6(4):321-30. doi: 10.1038/nrc1841. Nat Rev Cancer. 2006. PMID: 16557283 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results